Carl LeBel, Chief Development Officer at Frequency Therapeutics, Inc. (FREQ), sold 4,421 shares at $1.52 ($7K) on 2022-07-06, disclosed to the SEC on 2022-07-07.
Open-market sale of $7k FREQ by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| FREQ | SELL | 2022-02-16 | $4K | — | Filing → |
| OTIC | SELL | 2016-11-22 | $384K | — | Filing → |
| OTIC | SELL | 2016-09-08 | $381K | — | Filing → |